Spero Therapeutics Inc (SPRO)
1.20
-0.05
(-4.00%)
USD |
NASDAQ |
Nov 15, 09:53
Spero Therapeutics Total Return Level: 1.25 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 1.25 |
November 13, 2024 | 1.31 |
November 12, 2024 | 1.32 |
November 11, 2024 | 1.33 |
November 08, 2024 | 1.32 |
November 07, 2024 | 1.31 |
November 06, 2024 | 1.31 |
November 05, 2024 | 1.31 |
November 04, 2024 | 1.29 |
November 01, 2024 | 1.18 |
October 31, 2024 | 1.23 |
October 30, 2024 | 1.29 |
October 29, 2024 | 1.31 |
October 28, 2024 | 1.29 |
October 25, 2024 | 1.33 |
October 24, 2024 | 1.26 |
October 23, 2024 | 1.26 |
October 22, 2024 | 1.27 |
October 21, 2024 | 1.28 |
October 18, 2024 | 1.28 |
October 17, 2024 | 1.285 |
October 16, 2024 | 1.24 |
October 15, 2024 | 1.20 |
October 14, 2024 | 1.23 |
October 11, 2024 | 1.25 |
Date | Value |
---|---|
October 10, 2024 | 1.24 |
October 09, 2024 | 1.24 |
October 08, 2024 | 1.24 |
October 07, 2024 | 1.30 |
October 04, 2024 | 1.30 |
October 03, 2024 | 1.29 |
October 02, 2024 | 1.31 |
October 01, 2024 | 1.31 |
September 30, 2024 | 1.34 |
September 27, 2024 | 1.31 |
September 26, 2024 | 1.28 |
September 25, 2024 | 1.28 |
September 24, 2024 | 1.28 |
September 23, 2024 | 1.30 |
September 20, 2024 | 1.33 |
September 19, 2024 | 1.355 |
September 18, 2024 | 1.34 |
September 17, 2024 | 1.33 |
September 16, 2024 | 1.37 |
September 13, 2024 | 1.37 |
September 12, 2024 | 1.33 |
September 11, 2024 | 1.34 |
September 10, 2024 | 1.35 |
September 09, 2024 | 1.37 |
September 06, 2024 | 1.315 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.6801
Minimum
Aug 02 2022
22.07
Maximum
Dec 28 2020
7.181
Average
2.01
Median
Total Return Level Benchmarks
Arbutus Biopharma Corp | 3.63 |
Equillium Inc | 0.6842 |
NovaBay Pharmaceuticals Inc | 0.727 |
Palatin Technologies Inc | 1.07 |
iBio Inc | 2.15 |